Match Document Document Title
US20140363379 NUTRITIONAL APPROACH TO THE USE OF ERGOTHIONEINE AND VITAMIN D2 FOR HAIR, NAIL AND SKIN GROWTH  
Nutritional products, including food and/or beverage compositions, pharmaceutical and cosmetic preparations and methods of use are disclosed for the prevention, suppression and treatment of skin,...
US20120141446 Oral Nutritional Supplement Delivery System  
A composition for increasing the bioavailability of nutrients in humans and animals comprising an oil base emulsion into which nutrients selected from the group comprising omega fatty acids,...
US20140205648 METHODS FOR THE IN SITU TREATMENT OF BONE CANCER  
The present invention relates to methods for in situ treatment of malignant cells from a cancer associated with bone. In one method, the treatment is for a primary cancer and entails positioning...
US20110142904 Methods for the In Situ Treatment of Bone Cancer  
The present invention relates to methods for in situ treatment of malignant cells from a cancer associated with bone. In one method, the treatment is for a primary cancer and entails positioning...
US20110306579 METHODS OF NEUROPROTECTION USING NEUROPROTECTIVE STEROIDS AND A VITAMIN D  
Described herein are compositions and methods for treating or preventing nervous system injury. In particular, the methods and compositions relate to the use of at least one neuroprotective...
US20140186468 DIAGNOSING SUBSETS OF TRIPLE-NEGATIVE BREAST CANCER  
The present invention provides a unique combination of biomarkers that identify triple-negative breast cancer (TNBC) patient subpopulations. Such subpopulations will have differential responses to...
US20110311442 DIRECT CELLULAR ENERGY DELIVERY SYSTEM  
A lipid vesicle comprising a phospholipid which is a stable vesicle former and at least one unstable vesicle forming member, wherein the unstable vesicle forming member is selected from the group...
US20120196837 METHOD OF TREATING FRAILTY  
Disclosed is a method of treatment or prevention of frailty in an elderly patient, particularly having an age of 60 or older. The method provides the concomitant parenteral administration of a...
US20130210779 METHOD OF IDENTIFYING TRIPLE NEGATIVE BREAST CANCER  
The present invention provides means for identifying or classifying breast tumors based on the levels of nuclear cathepsin-L (CTSL) and nuclear p53 binding protein (53BP1), and methods of treating...
US20120322774 CHOCOLATE HAVING CHOLECALCIFEROL AND METHOD FOR FORMING  
A method for forming chocolate having cholecalciferol is provided. The method includes mixing cholecalciferol into an oil to produce a cholecalciferol-oil mixture. The temperature of a chocolate...
US20150216881 Method for Treating Secondary Hyperparathyroidism in CKD  
A stable, controlled release formulation for oral dosing of vitamin D compounds is disclosed. The formulation is prepared by incorporating one or more vitamin D compounds into a solid or...
US20120015916 Method for Treating Secondary Hyperparathyroidism in CKD  
A stable, controlled release formulation for oral dosing of vitamin D compounds is disclosed. The formulation is prepared by incorporating one or more vitamin D compounds into a solid or...
US20130295202 USE OF SELECTIVE ESTROGEN RECEPTOR MODULATOR FOR JOINT FUSION AND OTHER REPAIR OR HEALING OF CONNECTIVE TISSUE  
Methods for facilitating joint immobilization or fusion using selective estrogen receptor modulator (SERM) such as raloxifene are disclosed. The SERM may be administered systemically or locally....
US20120277180 Cofactors and Methods for Use for Individuals  
Provided herein are methods and systems for identifying one or more cofactors such as vitamins for individuals based on the genetic makeup of the individual by detecting the presence or absence of...
US20100310508 METHODS OF TREATMENT INVOLVING p21/CIP1  
The onset ratios and pathological conditions of collagen-induced arthritis and adjuvant arthritis in model mice and rats, respectively, were successfully ameliorated by topically expressing the...
US20110311651 CARDENOLIDES FOR THE TREATMENT OF OCULAR CANCER  
The instant invention provides methods of using a class of compounds known as cardenolides in the treatment of proliferative diseases such as cancer. In particular, the instant invention provides...
US20150246061 VITAMIN D ANALOGUES FOR THE TREATMENT OF A NEUROLOGICAL DISORDER  
Disclosed herein are methods that use a vitamin D analogue to treat a neurological disorder. Additionally, pharmaceutical compositions comprising a vitamin D analogue and a neurotherapeutic agent...
US20140187521 AMELIORATION OF INTESTINAL FIBROSIS AND TREATMENT OF CROHN'S DISEASE  
Methods of treating patients with inflammatory bowel disease, intestinal fibrosis, or Crohn's disease involve administering a therapeutic amount of CARD-024 or related compound.
US20140357603 Methods for Controlled Release Oral Dosage of a Vitamin D Compound  
A stable, controlled release formulation for oral dosing of vitamin D compounds is disclosed. The formulation is prepared by incorporating one or more vitamin D compounds into a solid or...
US20130131022 Methods for Controlled Release Oral Dosage of a Vitamin D Compound  
A stable, controlled release formulation for oral dosing of vitamin D compounds is disclosed. The formulation is prepared by incorporating one or more vitamin D compounds into a solid or...
US20150190365 Combination Dosage Forms and Therapies For Supporting Bone Health  
Combined therapies and oral dosage forms based on genistein for the support of osteoporotic health.
US20130078318 COMBINATION DOSAGE FORMS AND THERAPIES FOR SUPPORTING BONE HEALTH  
Combined therapies and oral dosage forms based on genistein for the support of osteoporotic health.
US20110200542 SKIN CANCER PREVENTION METHOD AND PRODUCT  
The increased use of sunscreens, while limiting damage to the DNA, may promote cancer growth by preventing vitamin D synthesis in the skin. According to the present invention, the beneficial...
US20150247872 ASSAYS AND METHODS OF TREATMENT RELATING TO VITAMIN D INSUFFICIENCY  
Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate...
US20140113885 ASSAYS AND METHODS OF TREATMENT RELATING TO VITAMIN D INSUFFICIENCY  
Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate...
US20130324505 ASSAYS AND METHODS OF TREATMENT RELATING TO VITAMIN D INSUFFICIENCY  
Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate...
US20130017234 IMPLANT MODIFIED WITH NON-HYDROXYLATED VITAMIN D PRECURSORS  
An implant to be used as medical or dental implant, comprising a metallic or polymeric base which is covered by the vitamin D precursor cholecalciferol. The implant can be obtained by direct...
US20120100223 LIPID-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF  
Lipid compositions comprising nuts, seeds, oils, legumes, fruits, grains, and dairy useful in specified amounts as dietary supplements and diet plans designed around and including the...
US20120190656 METHODS FOR SELECTING THERAPIES TO IMPROVE HDL CHOLESTEROL AND TRIGLYCERIDE LEVELS  
Disclosed herein are diagnostic methods for determining whether subjects will be responsive to vitamin D therapy. The methods involve the detection of one or more single nucleotide polymorphisms...
US20150250752 COMPOSITION CONTAINING LYSINE AS A NUTRITIONAL SUPPLEMENT OR TREATMENT IN THE CASE OF HERPES  
The invention relates to a composition comprising, related to a daily dose of the composition, as its active ingredients L-lysine ranging from ≧750 mg to −9 g, suitable as a nutritional supplement...
US20110034426 Method of Preventing Renal Disease and Treating Symptoms Thereof  
The invention relates to novel methods of using 2-methylene-19-nor-20(S)-1,25-dihydroxyvitamin D3 to prevent renal disease, particularly Lupus nephritis, in a subject at risk of developing renal...
US20090017136 Formulation to prevent and treat fibromyalgia, depression and other muscle and nervous system disorders  
The formulation provides for the treatment and prevention of fibromyalgia, depression and other muscle and nervous system disorders. The formulation combines Coenzyme Q10, vitamin B1,...
US20110020270 TREATMENT AND PROPHYLAXIS  
This invention discloses the use of an E-selectin antagonist and a mobilizer of hematopoietic stem cells or progenitor cells in methods and compositions for treating or preventing...
US20130143806 METHOD FOR EARLY PROGNOSIS OF KIDNEY DISEASE  
Certain embodiments of the present invention relate to methods for detecting kidney disease, in particular early stage kidney disease.
US20140303124 METHODS AND COMPOSITIONS FOR THE TREATMENT OF MIGRAINE HEADACHES  
The present invention is related to compositions and methods for treating or reducing the likelihood of a migraine, reducing the severity of migraine, reducing the frequency of migraines, reducing...
US20120329764 METHODS AND COMPOSITIONS FOR THE TREATMENT OF MIGRAINE HEADACHES  
The present invention is related to compositions and methods for treating or reducing the likelihood of a migraine, reducing the severity of migraine, reducing the frequency of migraines, reducing...
US20060154902 Shortening of hospital stay and improving survival in patients with chronic kidney disease  
Formulations containing a Vitamin D compound or analog, such as paricalcitol (Zemplar™) are useful for shortening hospital stays in chronic kidney disease patients with or without...
US20140088049 METHOD AND APPARATUS FOR VITAMIN D ENHANCEMENT IN MUSHROOMS  
An apparatus and method for increasing Vitamin D content in mushrooms is disclosed. A mushroom slurry of comminuted or pulverized mushrooms or mushroom parts and liquid, such as water, is passed...
US20130085121 PHARMACEUTICAL COMPOSITIONS COMPRISING PHOSPHATE BINDER, CALCIUM RECEPTOR-ACTIVE COMPOUND AND/OR ACTIVE VITAMIN D  
The present invention is an oral solid pharmaceutical compositions for the treatment of kidney diseases and mineral bone disorder including a phosphate binder, a calcium receptor-active compound...
US20140348938 PROCESS FOR PREPARING SOLID LIPID SUSTAINED RELEASE NANOPARTICLES FOR DELIVERY OF VITAMINS  
The present invention relates to a simple and convenient process for preparing solid lipid sustained release nanoparticles for delivery of drugs/vitamins, preferably fat soluble vitamins and more...
US20140349979 STABILIZED MODIFIED RELEASE VITAMIN D FORMULATION AND METHOD OF ADMINISTERING SAME  
A stabilized formulation for controlled release of a vitamin D compound is disclosed. The formulation comprises one or both of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 and a cellulosic...
US20140121156 NUTRITIONAL APPROACH TO THE CONTROL OF ANEMIA, DIABETES AND OTHER DISEASES OR CONDITIONS AND PREVENTION OF ASSOCIATED COMORBID STATES WITH THE USE OF ERGOTHIONEINE  
Nutritional products, compositions, pharmaceutical preparations and methods of use are disclosed for the prevention, suppression and treatment of anemia and/or diabetes and its various associated...
US20140100203 ONCE-A-WEEK ADMINISTRATION OF 25-HYDROXY VITAMIN D3 TO SUSTAIN ELEVATED STEADY-STATE PHARMACOKINETIC BLOOD CONCENTRATION  
An oral dosage form comprising a single dose of 25-hydroxy-vitamin D3 sufficient to elevate the serum level in a human to a concentration in the range of 30 ng/ml to 200 ng/ml for at least 7 days...
US20110105444 ONCE-A-WEEK ADMINISTRATION OF 25-HYDROXY VITAMIN D3 TO SUSTAIN ELEVATED STEADY-STATE PHARMACOKINETIC BLOOD CONCENTRATION  
An oral dosage form comprising a single dose of 25-hydroxy-vitamin D3 sufficient to elevate the serum level in a human to a concentration in the range of 30 ng/ml to 200 ng/ml for at least 7 days...
US20100075933 INJECTABLE COMPOSITIONS OF VITAMIN D COMPOUNDS  
Pharmaceutical injectable compositions comprising at least one vitamin D compound as an active agent, processes for preparing such compositions, and methods of using such compositions.
US20120115804 COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING NEOPLASIA  
The invention features compositions and methods for characterizing the methylation status of the Vitamin D Receptor (VDR) in neoplasia (e.g., breast carcinoma), selecting an appropriate therapy,...
US20120015915 FORMULATIONS OF 14-EPI-ANALOGUES OF VITAMIN D  
The present invention provides new formulations of 14-epi-analogues of vitamin D, such as inecalcitol, providing improved absorption profile.
US20120015914 FORMULATIONS OF 14-EPI-ANALOGUES OF VITAMIN D  
The present invention provides new formulations of 14-epi-analogues of vitamin D, such as inecalcitol, providing improved absorption profile.
US20120015913 Formulations of 14-EPI-Analogues of Vitamin D  
The present invention provides new formulations of 14-epi-analogues of vitamin D, such as inecalcitol, providing improved absorption profile.
US20130095154 TOPICAL VITAMIN D ORAL SUPPLEMENT COMPOSITIONS  
Topical, vitamin D, oral supplement compositions useful in treating oral inflammation comprising vitamin D in an aqueous-free emulsion containing a trans-oral mucosal absorption facilitator, where...